SMDAM
UTHR icon

Sumitomo Mitsui DS Asset Management’s United Therapeutics UTHR Stock Holding History

Sumitomo Mitsui DS Asset Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.57M Buy
4,746
+54
+1% +$30.4K 0.02% 498
2026
Q1 		$2.78M Sell
4,692
-370
-7% -$184K 0.02% 443
2025
Q4 		$2.47M Buy
5,062
+1,146
+29% +$534K 0.02% 480
2025
Q3 		$1.64M Sell
3,916
-323
-8% -$109K 0.01% 548
2025
Q2 		$1.22M Sell
4,239
-165
-4% -$49.3K 0.01% 591
2025
Q1 		$1.36M Buy
4,404
+11
+0.3% +$3.77K 0.01% 569
2024
Q4 		$1.55M Sell
4,393
-21
-0.5% -$7.72K 0.02% 542
2024
Q3 		$1.58M Buy
4,414
+11
+0.2% +$3.72K 0.02% 538
2024
Q2 		$1.4M Buy
4,403
+511
+13% +$135K 0.02% 532
2024
Q1 		$894K Hold
3,892
– – 0.01% 615
2023
Q4 		$856K Buy
3,892
+61
+2% +$14.1K 0.01% 641
2023
Q3 		$865K Sell
3,831
-15
-0.4% -$3.46K 0.01% 591
2023
Q2 		$849K Buy
3,846
+152
+4% +$33.7K 0.01% 601
2023
Q1 		$827K Buy
+3,694
New +$911K 0.01% 589
2019
Q2 		– Sell
-2,514
Closed -$295K – 799
2019
Q1 		$295K Hold
2,514
– – ﹤0.01% 758
2018
Q4 		$273K Sell
2,514
-360
-13% -$41.7K ﹤0.01% 743
2018
Q3 		$367K Sell
2,874
-133
-4% -$16.5K 0.01% 741
2018
Q2 		$340K Hold
3,007
– – 0.01% 740
2018
Q1 		$337K Buy
3,007
+2
+0.1% +$254 0.01% 744
2017
Q4 		$444K Sell
3,005
-84
-3% -$10.7K 0.01% 727
2017
Q3 		$361K Hold
3,089
– – 0.01% 710
2017
Q2 		$400K Hold
3,089
– – 0.01% 710
2017
Q1 		$418K Sell
3,089
-61
-2% -$9.24K 0.01% 694
2016
Q4 		$451K Sell
3,150
-44
-1% -$5.62K 0.01% 662
2016
Q3 		$377K Hold
3,194
– – 0.01% 671
2016
Q2 		$338K Buy
3,194
+50
+2% +$5.58K 0.01% 660
2016
Q1 		$350K Hold
3,144
– – 0.01% 655
2015
Q4 		$492K Hold
3,144
– – 0.02% 591
2015
Q3 		$412K Buy
3,144
+4
+0.1% +$642 0.01% 624
2015
Q2 		$546K Buy
+3,140
New +$565K 0.02% 609

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Sumitomo Mitsui DS Asset Management's UTHR Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its United Therapeutics (UTHR) stake by 1.2% in Q2 2026, buying an estimated $30.4K and bringing the position to 4,746 shares worth $2.57M. The position accounts for 0.02% of the portfolio, ranked #498.

Sumitomo Mitsui DS Asset Management first reported a position in UTHR in Q2 2015 and has held it in 30 quarters since. The position peaked at $2.78M in Q1 2026. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 4,746 shares of United Therapeutics worth $2.57M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 54 United Therapeutics shares in Q2 2026, an estimated $30.4K.
  • United Therapeutics made up 0.02% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #498 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in United Therapeutics in Q2 2015 and has held it in 30 quarters since.
  • Sumitomo Mitsui DS Asset Management's United Therapeutics position peaked at $2.78M in Q1 2026.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.